Intelligence · Clinical pipeline
Metabolic & obesity · Phase II
Metabolic & obesity programs at Phase II — ClinicalTrials.gov pipeline intelligence.
Programs 11
Quick answer
Metabolic & obesity Phase II programs: NovaPharmaNews indexes 11 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Takeda 13 programs
- IONIS PHARMACEUTICALS 10 programs
- Oramed Pharmaceuticals 10 programs
- Regeneron UK 10 programs
- United Therapeutics Europe 7 programs
- Anaxis Pharma 6 programs
- NovoThirteen 6 programs
- Vertex Pharmaceuticals (Australia) 6 programs
- vTv Therapeutics 6 programs
- Alnylam Netherlands 5 programs
- LEXICON PHARMACEUTICALS 5 programs
- Rhythm Pharmaceuticals Netherlands 5 programs
Pipeline programs
-
ARO-INHBE
Arrowhead Pharmaceuticals Ireland Limited
Obesity
1 trial -
BC45538
Hoffmann-La Roche
Obesity
1 trial -
EP-005
Lacuna Pharma Pty Ltd
Obesity
1 trial -
ISIS-FGFR4RX
IONIS PHARMACEUTICALS INC
Obesity
1 trial -
KAI-7535
Kailera Therapeutics
Obesity
2 trials -
Naltrexone hydrochloride
BRIGHT MINDS BIOSCIENCES INC.
Obesity
1 trial -
Pramlintide+Metreleptin
Takeda
Obesity
1 trial -
TTP435
vTv Therapeutics
Obesity
1 trial -
Tirzepatide
Regeneron UK Limited
Obesity
1 trial -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Obesity
1 trial -
aleniglipron or placebo
Structure Therapeutics
Obesity
1 trial
Frequently asked questions
How many metabolic & obesity Phase II programs exist?
11 programs match both the therapeutic area and stage filters in our published index.